Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative medicines to treat central nervous system (CNS) disorders, particularly those with high unmet needs. The company has a strong track record of success, having developed and commercialized the first and only FDA-approved treatments for hallucinations and delusions associated with Parkinson’s disease psychosis and Rett syndrome. Acadia's pipeline includes promising investigational therapies for Prader-Willi syndrome, Alzheimer's disease psychosis, and other neuropsychiatric symptoms in CNS disorders.

Beyond their treatment development, Acadia is committed to improving the lives of patients and their families. This commitment is demonstrated through their patient support programs, community engagement initiatives, and corporate social responsibility efforts. The company is dedicated to fostering a diverse and inclusive workplace, supporting clinical trial diversity, and partnering with patient advocacy organizations to address health inequalities and raise awareness of the diseases they are working to treat.

Acadia Pharmaceuticals offers a variety of flexible work arrangements to support employee well-being and work-life balance. Their Total Rewards program includes paid vacation and holidays, paid sick time, and an Employee Assistance Program (EAP). Some positions, particularly in sales and medical affairs, are offered remotely. Additionally, Acadia is committed to diversity, equity, and inclusion, which includes supporting flexible work arrangements for all employees.

Acadia Pharmaceuticals offers a competitive Total Rewards program designed to support employee well-being and financial security. Benefits include comprehensive health insurance plans, dental and vision coverage, flexible spending accounts, a 401(k) plan with a company match, an employee stock purchase plan, income protection through disability benefits and life insurance, as well as work-life balance benefits like paid vacation and holidays, sick time, an Employee Assistance Program, and education assistance.

Acadia Pharmaceuticals is a neuroscience company dedicated to "elevating life" by developing innovative treatments for people with neurological disorders. They are driven by their commitment to science and their passion for finding solutions to unmet medical needs, particularly in areas like Parkinson's disease psychosis, Rett syndrome, Prader-Willi syndrome, and Alzheimer's disease psychosis.

Acadia Pharmaceuticals promotes a culture of curiosity, belonging, sustainability, and ethics. They value a diverse workforce and foster an inclusive environment where employees can bring their whole selves to work. They are committed to supporting their employees' well-being and development, and they encourage giving back to the community through various initiatives. The company strives to be a responsible corporate citizen by upholding high ethical standards and minimizing their environmental impact.

Acadia Pharmaceuticals is committed to fostering a culture of curiosity and belonging where all employees feel welcome to bring their whole selves to work. They have established employee resource groups (ERGs) to foster inclusion based on shared experiences and values, and they have implemented strategic initiatives to promote a culture of curiosity and belonging. Acadia also prioritizes diverse representation in clinical trials, believing that it is essential to developing therapies that are broadly applicable and promote healthcare equity.